Clin Osteol 2014; 19(1): 3-9

Osteoporosis in chronic lung diseasesReview articles

M. ®urek, P. Horák

Keywords: osteoporóza, zlomeniny, chronická bronchitída, astma bronchiole, cystická fibróza, sarkoidóza, transplantace plic, inhalační kortikoidy v SUMMARY

Published: June 11, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
®urek M, Horák P. Osteoporosis in chronic lung diseases. Osteologický bulletin. 2014;19(1):3-9.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rabe KF, Hurd S, Anzueto A et al. Global initiative for chronic obstructive lung disease global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;15:532-555. Go to original source...
    2. WHO Scientific Group on the Prevention and Management of Osteoporosis. Prevention and Management of Osteoporosis: report of a WHO scientific group. WHO_TRS_921.pdf. Date last accessed: December 2, 2008. http://whqlibdoc.who.int/trs/
    3. Giversen IM. Time trends of mortality after first hip fractures. Osteoporos Int 2007;18:721-732. Go to original source...
    4. Ákesson K, Woolf DA Bone: Risk of death persists for years after hip fracture. Nat Rev Rheumatol 2010;6:557-558. Go to original source...
    5. Khan MA, Hossain FS, Ahmed I, Muthukumar N, Mohsen A Predictors of early mortality after hip fracture surgery. Int Orthop 2013;37(11):2119-2124. Go to original source...
    6. Levi N. Urinary tract infection and cervical hip fracture. Int J Risk Safety Med 1998;11:41-44. Go to original source...
    7. Koot VC, Jfeeters PH, de Jong JR, Clevers GJ, van der Werken C. Functional results after treatment of hip fracture: a multicentre, prospective study in 215 pa­ tients. Eur J Surg 2000;166:480 485. Go to original source...
    8. Biskobing DM. COPD and osteoporosis. Chest 2002;121:609-620. Go to original source...
    9. Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J 2003;22(Suppl 4):64-75. Go to original source...
    10. Leech JA et al. Relationship of lung function to severity of osteoporosis in wo­ men. Am Rev Respir Dis 1990;141:68-71. Go to original source...
    11. Schlaich C, Minne HW, Bruckner T et al. Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int 1998;8:261-267. Go to original source...
    12. Kado DM, Browner WS, Palermo L et al. Vertebral fractures and mortality in ol­ der women: a prospective study. Study of osteoporotic fractures research group. Arch Intern Med 1999;159:1215-1220. Go to original source...
    13. Compston JE. Risk factors for osteoporosis. Clin Endocrinol (Oxf) 1992;36: 223-224. Go to original source...
    14. Goldring SR. Pthogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 2002;14:406-410. Go to original source...
    15. Lane NE. Therapy insight: osteoporosis and osteonecrosis in systemic lupus ery­ thematosus. Nat Clin Pract Rheumatol 2006;2:562-569. Go to original source...
    16. Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med 2009;122:599-604. Go to original source...
    17. Lacativa PG, Farias ML. Osteoporosis and inflammation. Arq Bras Endocrinol Metabol 2010;54:123-132. Go to original source...
    18. Bolton CE, Evans M, Ionescu AA et al. Insulin resistance and inflammation: a further systemic complication of COPD. COPD 2007;4:121-126. Go to original source...
    19. Bai P, Sun Y, Jin J, Hou J, Li R, Zhang Q, Wang Y. Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir Res 2011;12:157. Go to original source...
    20. Dimai HP, Domej W, Leb G, Lau KH. Bone loss in patiens with untreated chro­ nic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia. J Bone Miner Res 2001;16:2132-2141. Go to original source...
    21. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive sum­ mary. Am J Respir Crit Care Med 2007;176:532-555. Go to original source...
    22. Schols AM, Broekhuizen R, Weling-Scheepers CA et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82: 53-59. Go to original source...
    23. Wouters EF. Introduction: systemic effects in chronic obstructive pulmonary di­ sease. Eur Respir J Suppl 2003;46:1. Go to original source...
    24. van Weel C, Schellevis FG. Comorbidity and guidelines: conflicting interests. Lancet 2006;367:550- 551. Go to original source...
    25. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005;2:367-370. Go to original source...
    26. Sabit R, Bolton CE, Edwards PH et al. Arterial stiffness and osteoporosis in chro­ nic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 1259-1265. Go to original source...
    27. Graat-Verboom L, Spruit MA, van den Borne BE et al. CIRO Network. Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated sys­ temic component. Respir Med 2009;103:1143-1151. Go to original source...
    28. Ferguson GT, Calverley PM, Anderson JA et al. Prevalence and Progression of Osteoporosis in Patients with COPD: Results from the towards a Revolution in COPD health Study. Chest 2009;136:1456-1465. Go to original source...
    29. Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med 2003;114:10-14. Go to original source...
    30. Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS. Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treat­ ment, body mass index, and gonadal function. Chest 1999;116:1616-1624. Go to original source...
    31. Bolton CE, Ionescu AA, Shiels KM et al. Associated loss of fat-free mass and bo­ ne mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:1286-1293. Go to original source...
    32. F0rli L, Mellbye OJ, Halse J, Bj0rtuft O, Vatn M, Boe J. Cytokines, bone turnover markers and weight change in candidates for lung transplantation. Pulm Pharmacol Ther 2008;21:188-195.
    33. Shepherd AJ, Cass AR, Carlson CA et al. Development and internal validation of the male osteoporosis risk estimation score. Ann Fam Med 2007;5:540-546. Go to original source...
    34. McEvoy CE, Ensrud KE, Bender E et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:704-709. Go to original source...
    35. Ihpaioannou A, Parkinson W, Ferko N et al. Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada. Osteoporos Int 2003;14:913-917. Go to original source...
    36. de Vries F, van Staa TP, Bracke MS et al. Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 2005;25:879-884. Go to original source...
    37. Jorgensen NR, Schwarz P, Holme I, Henriksen BM, Ibtersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disea­ se: a cross sectional study. Respir Med 2007;101:177-185. Go to original source...
    38. Mineo TC, Ambrogi V, Mineo D, Fabbri A, Fabbrini E, Massoud R. Bone mine­ ral density improvement after lung volume reduction surgery for severe emphyse­ ma. Chest 2005;127:1960-1966. Go to original source...
    39. Lidwien Graat-Verboom, Ben EEM, van den Borne, Frank W, Smeenk JM, Spruit MA, Wouters EFM. Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. Journal of Bone and Mineral Research 2011; 26:561-568. Go to original source...
    40. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic ob­ structive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-580. Go to original source...
    41. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pul­ monary function in the third national health and nutrition examination survey. Chest 2005;128:3792-3798. Go to original source...
    42. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010;65:215-220. Go to original source...
    43. Celli BR, Cote CG, Marin JM, Casanova C, Montes de OM, Mendez RA et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012. Go to original source...
    44. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutri­ tional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-1861. Go to original source...
    45. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pul­ monary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83. Go to original source...
    46. Hitzl AP, Jorres RA, Heinemann F, Pfeifer M, Budweiser S. Nutritional status in patients with chronic respiratory failure receiving home mechanical ventilation: impact on survival. Clin Nutr 2010;29:65-71. Go to original source...
    47. National Asthma Education and Prevention Program: Expert panel report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051) www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on January 05, 2012).
    48. Efthimiou J, Barnes PJ. Effect of inhaled corticosteroids on bones and growth. Eur Respir J 1998;11:1167-1177. Go to original source...
    49. Scanlon PD, Connett JE, Wise RA, Tashkin DP, Madhok T, Skeans M, Carpenter PC, Bailey WC, Buist AS, Eichenhorn M, Kanner RE, Weinmann G. Lung Health Study Research Group. Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med 2004;170:1302-1309. Go to original source...
    50. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 2001;345:941-947. Go to original source...
    51. Ip M, Lam K, Yam L, Kung A, Ng M. Decreased bone mineral density in preme­ nopausal asthma patients receiving long-term inhaled steroids. Chest 1994;105: 1722-1727. Go to original source...
    52. Wong CA, Walsh LJ, Smith CJ, Wisniewski AF, Lewis SA, Hubbard R, Cawte S, Green DJ, Pringle M, Tattersfield AE. Inhaled corticosteroid use and bone-mine­ ral density in patients with asthma. Lancet 2000;355:1399-1403. Go to original source...
    53. Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) 1986;293:1463-1466. Go to original source...
    54. Hubbard RB, Smith CJ, Smeeth L, Harrison TW, Tattersfield AE. Inhaled corti­ costeroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med 2002;166:1563-1566. Go to original source...
    55. Hubbard R, Tattersfield A, Smith C, West J, Smeeth L, Fletcher A Use of inhaled corticosteroids and the risk of fracture. Chest 2006;130:1082-1088. Go to original source...
    56. Matsumoto H, Ishihara K, Hasegawa T, Umeda B, Niimi A, Hino. Effects of in­ haled corticosteroid and short courses of oral corticosteroids on bone mineral den­ sity in asthmatic patients:a 4year longitudinal study. Chest 2001;120:1468-1473. Go to original source...
    57. Tattersfield AE, Town GI, Johnell O, Picado C, Aubier M, Braillon P, Karlstrom R. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax 2001;56:272-278. Go to original source...
    58. Hughes JA, Conry BG, Male SM, Eastell R. One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density. Thorax 1999;54:223-229. Go to original source...
    59. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002;1:CD003537. Go to original source...
    60. Suissa S, Baltzan M, Kremer R, Ernst P. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med 2004;169:83-88. Go to original source...
    61. Sedlák V, Chlumský J, Teřl M et al. Doporučený postup diagnostiky a léčby ob­ tíľně léčitelného bronchiálního astmatu NTCA 2009.. www.pneumologie.cz
    62. Wilcox A, Bharadwaj P, Sharma OP. Bone sarcoidosis. Curr Opin Rheumatol 2000;12:321-330. Go to original source...
    63. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281. Go to original source...
    64. Stechschulte SA, Kirsner RS, Federman DG. Vitamin D: bone and beyond, ratio­ nale and recommendations for supplementation. Am J Med 2009;122:793-802. Go to original source...
    65. Stoffels K, Overbergh L, Giulietti A, Verlinden L, Bouillon R et al. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J Bone Miner Res 2006;21:37^7. Go to original source...
    66. Baughman RP, Teirstein AS, Judson MA et al. Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a ca­ se control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885-1889. Go to original source...
    67. Montemurro L, Fraioli P, Riboldi A, Delpiano S, Zanni D et al. Bone loss in pred­ nisone treated sarcoidosis: a two-year follow-up. Ann Ital Med Int 1990;5:164-168.
    68. Rizzato G, Tosi G, Mella C, Montemurro L, Zanni D et al. Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women. Sarcoidosis 1988;5:93-98.
    69. Montemurro L, Fraioli P, Rizzato G. Bone loss in untreated longstanding sarcoi­ dosis. Sarcoidosis 1991;8:29-34.
    70. Burke RR, Rybicki BA, Rao DS. Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med 2010;31:474-484. Go to original source...
    71. Sweiss NJ, Lower EE, Korsten P, Niewold TB, Favus MJ, Baughman RP. Bone health issues in sarcoidosis. Curr Rheumatol Rep 2011;13:265-272. Go to original source...
    72. Morimoto T, Azuma A, Abe S et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008;31:372-379. Go to original source...
    73. Mahe'vas M, Lescure FX, Boffa JJ et al. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 2009;88:98-106. Go to original source...
    74. Montemurro L, Schiraldi G, Fraioli P, Tosi G, Riboldi A, Rizzato G. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 1991;49:71-76. Go to original source...
    75. Gonnelli S, Rottoli P, Cepollaro C et al. Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients. Calcif Tissue Int 1997;61: 382-385. Go to original source...
    76. Loą»áková V, Kolek V, Vaąáková M. Sarkoidóza - doporučený postup diagnostiky, terapie a sledování vývoje onemocnění 2011.. www.pneumologie.cz
    77. Grey V, Atkinson S, Drury D et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian cen­ ters. Pediatrics 2008;122:1014-1020. Go to original source...
    78. Aris RM, Merkel PA, Bachrach LK et al. Guide to bone health and disease in cys­ tic fibrosis. J Clin Endocrinol Metab 2005;90:1888-1896. Go to original source...
    79. Aris RM, Renner JB, Winders AD et al. Increased rate of fractures and severe ky­ phosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998;128:186-193. Go to original source...
    80. Paccou J, Zeboulon N, Combescure C et al. The prevalence of osteoporosis, osteo­ penia, and fractures among adults with cystic fibrosis: a systematic literature re­ view with meta-analysis. Calcif Tissue Int 2010;86:1-7. Go to original source...
    81. Henderson RC, Specter BB. Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr 1994;125:208-212. Go to original source...
    82. Tangpricha V, Kelly A, Stephenson K et al. An update on the screening, diagno­ sis, management, and treatment of vitamin D deficiency in individuals with cys­ tic fibrosis: Evidence-based recommendations from the Cystic Fibrosis Foun­ dation. J Clin Endocrinol Metab 2012;97:1082-1086. Go to original source...
    83. Sermet-Gaudelus I, Bianchi ML, Garabédian M, Aris RM, Morton A, Hardin DS, Elkin SL, Compston JE, Conway SP, Castanet M, Wolfe S, Haworth CS. European cystic fibrosis bone mineralisation guidelines. J Cyst Fibros 2011; 10 Suppl 2:S16-23. Go to original source...
    84. Conwell LS, Chang AB. Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database Syst Rev 2012;4:CD002010. Go to original source...
    85. Marini JC. Do bisphosphonates make children's bones better or brittle? N Engl J Med 2003;349:423-425. Go to original source...
    86. Spira A et al. Gutierrez C, Chaparro C, Hutcheon MA, Chan CK. Osteoporosis and lung transplantation: a prospective study. Chest 2000;117:476-481. Go to original source...
    87. Ferrari SL, Nicod LP, Hamacher J, Spiliopoulos A, Slosman DO, Rochat T et al. Osteoporosis in patients undergoing lung transplantation. Eur Respir J 1996; 9:2378-2382. Go to original source...
    88. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disea­ se. Am J Med 1996;101:262-269. Go to original source...
    89. Julian BA, Laskow DA, Dubovsky J et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991;325:544-550. Go to original source...
    90. Horber FF, Casez JP, Steiger U et al. Changes in bone massearly after kidney transplantation. J Bone Miner Res 1994;9:1-9. Go to original source...
    91. Sambrook PN, Kelly PJ, Keogh A et al. Bone loss after cardiac transplantation: a prospective study. J Heart LungTransplant 1994;13:116-121.
    92. Meys E, Fontanges E, Foureade N et al. Bone loss after orthotopic liver trans­ plantation. Am J Med 1994;97:445^50. Go to original source...
    93. Epstein S, Shane E, Bilezekian J. Organ transplantation and osteoporosis. Curr Opin Rheumatol 1995;7:255-261. Go to original source...
    94. Aris RM, Neuringer IP, Weiner MA et al. Severe osteoporosis before and after lung transplantation. Chest 1996;109:1176-1183. Go to original source...
    95. Ferrari SL, Nicod LP, Hamacher J et al. Osteoporosis in patients undergoing lung transplantation. Eur Respir J 1996;9:2378-2382. Go to original source...
    96. Shane E, Silverberg S, Donovan D et al. Osteoporosis involving lung transplant candidates with end-stage pulmonary disease. Am J Med 1996;101:262-269. Go to original source...
    97. Emily M, Stein EM, Ortiz D, Jin Z, McMahon DJ, Shane E. Prevention of fractu­ res after solid organ transplantation: a meta-analysis. J Clin Endocrinol Metab 2011;96:3457-3465. Go to original source...
    98. Cummings SR, Karpf DB, Harris F et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002;112:281-289. Go to original source...
    99. Karpf DB, Shapiro DR, Seeman E et al. Alendronate Osteoporosis Treatment Study Groups. Prevention of nonvertebral fractures by alendronate: a meta-analysis. JAMA 1997;277:1159-1164. Go to original source...
    100. Langdahl BL, Marin F, Shane E et al. Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal sta­ tus. Osteoporos Int 2009;20:2095-104. Go to original source...

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.